Cholecystectomy vs EUS-guided GBD With Stone Removal
Launched by INSTITUTO ECUATORIANO DE ENFERMEDADES DIGESTIVAS · Sep 7, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is comparing two different treatments for patients with gallstones, a condition known as cholelithiasis. The traditional approach is a surgery called laparoscopic cholecystectomy, which involves removing the gallbladder. However, researchers are exploring a newer, less invasive method called endoscopic ultrasound-guided gallbladder drainage (EUS-guided GBD) combined with stone removal. This trial aims to find out if this newer method is safe and effective compared to the standard surgery.
To participate in this study, you need to be an adult between 18 and 89 years old with symptoms of gallstones confirmed by an ultrasound. You should also be a good candidate for either the standard surgery or the new EUS-guided procedure. If you join the trial, you will be monitored closely to see how well the new treatment works and to ensure your safety. It’s important to know that not everyone can participate, especially those with certain medical conditions or complications related to gallstones. If you're interested or have questions, you can discuss it with your healthcare provider for more personalized information.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults \>18 years old and \<89 years old
- • Adult symptomatic patients with gallstones documented by US
- • Subject is a suitable candidate for an elective laparoscopic cholecystectomy or an EUS-guided GBD
- • Patients or authorized representative give informed consent for endoscopic or surgical approach
- Exclusion Criteria:
- • Patients with hepato-pancreato-biliary diseases other than gallstones (tumors, obstructions, inflammation)
- • Patients with acute cholecystitis, cholangitis or choledocholithiasis.
- • Patients with gallbladder polyps, family history of gallbladder cancer, or any other high-risk factor for gallbladder cancer
- • Patient unable to give informed consent or refuse to participate.
- • Prior biliary intervention
- • Pregnancy or nursing
- • Any other medical condition that contraindicates surgical or endoscopic procedures
About Instituto Ecuatoriano De Enfermedades Digestivas
The Instituto Ecuatoriano de Enfermedades Digestivas (IEED) is a leading clinical research organization dedicated to advancing gastrointestinal health through innovative research and clinical trials. Committed to improving patient outcomes, IEED focuses on the prevention, diagnosis, and treatment of digestive diseases, leveraging state-of-the-art technology and a multidisciplinary team of experts. With a strong emphasis on ethical practices and patient safety, the institute collaborates with national and international partners to contribute to the global understanding of digestive disorders and enhance therapeutic options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guayaquil, Guayas, Ecuador
Patients applied
Trial Officials
Carlos Robles-Medranda, MD, FASGE
Principal Investigator
Instituto Ecuatoriano de Enfermedades Digestivas
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported